Long-term Administration of L-Arginine Improves Nitric Oxide Release From Kidney in Deoxycorticosterone Acetate-Salt Hypertensive Rats

  • Hayakawa, Hiroshi
  • Hirata, Yasunobu
  • Suzuki, Etsu
  • Kimura, Kenjiro
  • Kikuchi, Kazuya
  • Nagano, Tetsuo
  • Hirobe, Masaaki
  • Omata, Masao
Hypertension 23(6):p 752-756, June 1994.

To examine the effects of L-arginine (L-Arg) on endothelial function, we administered 0.5 g/L L-Arg in drinking water to deoxycorticosterone acetate (DOCA)-salt rats for 8 weeks and then measured nitric oxide (NO) release from isolated kidneys using a newly developed real-time chemiluminescence method. Renal pathology was also analyzed. Acetylcholine caused much smaller declines in renal perfusion pressure (10−7 mol/L acetylcholine: −24±2% [SEM] versus −50±2%, P<.001) and NO release in DOCA-salt rats (+3±1 versus +33±3 fmol/min per gram kidney weight, P<.001) compared with control rats. L-Arg did not influence the time course of systolic blood pressure elevation in DOCA-salt rats (211±5 versus 208±6 mm Hg, DOCA versus L-Arg/DOCA, P=NS). However, oral administration of L-Arg improved acetylcholine- induced declines in renal perfusion pressure (10−7 mol/L acetylcholine: L-Arg/DOCA, −39±3%, P<.01 versus DOCA). This change was associated with an increase in NO release by acetylcholine (10−7 mol/L acetylcholine: L-Arg/ DOCA, +10±1 fmol/min per gram kidney weight, P<.05 versus DOCA). However, morphological changes in renal vessels and glomeruli were similar between DOCA and L-Arg/DOCA rats. These results suggest that L-Arg administration partially reverses renal endothelial function with respect to vasorelaxation and NO release independent of blood pressure changes, indicating that hypertensive vessels seem to be depleted of L-Arg and/or have defects in the availability of L-Arg for NO synthesis.

Copyright © 1994 American Heart Association, Inc.
View full text|Download PDF